References
- Ohta N, Fukase S, Suzuki Y, et al. Treatments of various otolaryngological cystic diseases by OK-4321: its indications and limitations. Laryngoscope. 2010;120:2193–2196.
- Kim JH. Ultrasound-guided sclerotherapy for benign non-thyroid cystic mass in the neck. Ultrasonography. 2014;33:83–90.
- Kim MG, Kim SG, Lee JH, et al. The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts. Laryngoscope. 2008;118:2177–2181.
- Ohta N, Fukase S, Suzuki Y, et al. Treatment of salivary mucocele of the lower lip by OK-432. Auris Nasus Larynx. 2011;38:240–243.
- Ohta N, Fukase S, Watanabe T, et al. Treatment of thyroglossal duct cysts by OK-432. Laryngoscope. 2012;122:131–133.
- Ohta N, Fukase S, Watanabe T, et al. Effects and mechanism of OK-432 therapy in various neck cystic lesions. Acta Otolaryngol. 2010;130:1287–1292.
- Fukase S, Ohta N, Inamura K, et al. Treatment of ranula wth intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol. 2003;112:214–220.
- Kim MH, Chung JH. Failure of sclerotherapy in the treatment of thyroglossal duct cyst in children: 2 case reports and review of the literature. J Pediatr Surg. 2012;47:E37–E40.
- Knipping S, Goetze G, Neumann K, et al. Sclerotherapy of cervical cysts with Picibanil (OK-432). Eur Arch Otorhinolaryngol. 2007;264:423–427.
- Kaselas C, Tsikopoulos G, Chortis C, et al. Thyroglossal duct cyst’s inflammation. When do we operate? Pediatr Surg Int. 2005;21:991–993.
- Ali AA, Al-Jandan B, Suresh CS, et al. The relationship between the location of thyroglossal duct cysts and the epithelial lining. Head Neck Pathol. 2013;7:50–53.